⚕ GalenOps field
←

710-1060

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-01-01

AEs
8
Serious
0
Dropout signal
–

Adverse events

mild assessed

Mild APPLICATION SITE INDURATION — outcome: RECOVERED/RESOLVED; onset 2013-01-21 (study day 21.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-23 (study day 23.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-31 (study day 31.0); relationship: POSSIBLE

mild assessed

Mild FALL — outcome: RECOVERED/RESOLVED; onset 2013-02-08 (study day 39.0); relationship: NONE

mild assessed

Mild FALL — outcome: RECOVERED/RESOLVED; onset 2013-02-09 (study day 40.0); relationship: NONE

mild assessed

Mild INSOMNIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-04 (study day 4.0); relationship: NONE

mild assessed

Mild INSOMNIA — outcome: RECOVERED/RESOLVED; onset 2013-01-04 (study day 4.0); relationship: NONE

mild assessed

Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2013-01-02 (study day 2.0); relationship: NONE

Data queries

No data queries.